TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose-Reference-Cited by-同舟云学术

TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose

Published:2015-05 Issue: Volume:18 Page:199-208
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Schatz U.,Illigens B.M.W.,Siepmann T.,Arneth B.,Siegert G.,Siegels D.,Heigl F.,Hettich R.,Ramlow W.,Prophet H.,Bornstein S.R.,Julius U.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference35 articles.

1. Iron, anemia, and inflammatory bowel diseases;Gasche;Gut,2004

2. Ferric carboxymaltose in patients with heart failure and iron deficiency;Anker;N Engl J Med,2009

3. Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls;Bruner;Lancet,1996

4. Iron deficiency in patients undergoing lipoprotein apheresis and its management;Schatz;Atheroscler Suppl,2013

5. Impact of regular LDL apheresis on the development of restless legs syndrome;Tings;Mov Disord,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis;The American Journal of Cardiology;2020-12

2. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity;Pediatric Nephrology;2018-03-03

3. Ferric Carboxymaltose: A Review in Iron Deficiency;Drugs;2018-03

4. Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection;Medical Devices: Evidence and Research;2016-10

5. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease;Arteriosclerosis, Thrombosis, and Vascular Biology;2016-09